EMJ Nephrology 12.1 2024

July 2024

In our latest issue of EMJ Nephrology, discover the latest in the field, featuring developments in antibody-mediated rejection in renal transplantation and immune complex-mediated membranoproliferative glomerulonephritis, challenges in renal replacement therapy, and a detailed review of the European Renal Association (ERA) 2024 Annual Global Congress. Plus, don’t miss our exclusive interviews with experts in nephrology!

Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis

Immune complex-mediated membranoproliferative glomerulonephritis (iMPGN) can develop in association with autoimmune diseases such as… Please rate the quality of this content Submit Rating As you found this content interesting... Follow us on social media! We are sorry that this content was not interesting for you! Let us improve this content! Tell us how we can improve this content? Submit Feedback

Challenges in Renal Replacement Therapy in Resource-limited Settings

Chronic kidney disease (CKD) continues to be a global public health problem. Globally, the prevalence of CKD is approximately 8–16% in the… Please rate the quality of this content Submit Rating As you found this content interesting... Follow us on social media! We are sorry that this content was not interesting for you! Let us improve this content! Tell us how we can improve this content? Submit Feedback

End-Stage Renal Disease and Neurological Connection

Due to the incapacitating nature of end-stage renal disease, people on dialysis frequently acquire undetected psychopathological disorders. Please rate the quality of this content Submit Rating As you found this content interesting... Follow us on social media! We are sorry that this content was not interesting for you! Let us improve this content! Tell us how we can improve this content? Submit Feedback

Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients

In 2022, over 92,000 kidney transplants were performed globally.1 With advancements in transplant science, 1-year graft survival rates… Please rate the quality of this content Submit Rating As you found this content interesting... Follow us on social media! We are sorry that this content was not interesting for you! Let us improve this content! Tell us how we can improve this content? Submit Feedback

EMJ Nephrology 12.1 2024

In this issue

Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis

Challenges in Renal Replacement Therapy in Resource-limited Settings

End-Stage Renal Disease and Neurological Connection

Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients

Therapy Area

About Us

EMJ Nephrology 12.1 2024

In this issue

Latest articles

Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis

Challenges in Renal Replacement Therapy in Resource-limited Settings

End-Stage Renal Disease and Neurological Connection

Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients